Survey on patients using anticoagulant medications

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study collects data on patients who are starting or switching to anticoagulant treatments, including vitamin K antagonists and novel direct oral anticoagulants. It aims to evaluate the efficacy and safety of various anticoagulant therapies and improve understanding of their risks and benefits. Patients aged 18 and older are included if they are beginning anticoagulation therapy or switching from one type of anticoagulant to another, with a minimum expected treatment duration of three months. The study is designed to gather comprehensive clinical histories and treatment patterns over at least one year.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* age \>= 18 years

Exclusion Criteria:

* \< 18 years
* not willing to sign informed consent

Where it's running

• S. Orsola-Malpighi University hospital
  Bologna, Bo, Italy Recruiting

Study contacts

• Study coordinator: Gualtiero Palareti, MD
• Email: gualtiero.palareti@unibo.it
• Phone: + 328 2279868

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Registry for the use of NOACs in patients with Atrial Fibrillation or Venous Thromboembolism

  This study is looking to see how well new blood thinners called NOACs work for people with Atrial Fibrillation or blood clots, by tracking their treatment and outcomes over time.

  Recruiting Henan Provincial People's Hospital · Zhengzhou, Henan · NCT05378308

• Evaluating DOAC levels in Chinese patients with atrial fibrillation

  This study is testing how stopping blood-thinning medication for a short time affects Chinese patients with atrial fibrillation to see if it's safe for them during medical procedures.

  Recruiting Chinese University of Hong Kong · Hong Kong · NCT05378035

• AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals

  This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.

  Recruiting at 2 sites Hospital Universitari Vall d'Hebron Research Institute · Leuven and 6 other locations · NCT07924371

• DoACs vs LMWH for blood flow after knee replacement

  This study tests whether rivaroxaban, apixaban, or LMWH work differently to support blood flow in the legs after total knee replacement in adults.

  Recruiting Military Hospital of Tunis · Tunis, Tunis Governorate · NCT07869615

• Left-atrial Fibrosis in Persistent Atrial Fibrillation and Its Comorbidities

  This study tests how comorbid conditions like sleep apnea and primary aldosteronism relate to left-atrial fibrosis and AF recurrence in patients undergoing ablation.

  Recruiting University Hospital Augsburg · Augsburg, Bavaria · NCT07857044

• Dual Energy ablation with SmartTouch SF catheter in persistent atrial fibrillation

  This study tests a pulsed field and radiofrequency ablation system to treat persistent atrial fibrillation in adults who have not responded well to prior medications.

  Recruiting at 4 sites Biosense Webster, Inc. · Beijing and 3 other locations · NCT07845682

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.